|  中文 / English
LATEST DATA

Innovative Community

Human Resources

BioBay High-level Talent Scheme

NEWS

    Dr. Wang Peng Elected as a Fellow of American Institute for Medical and Biological Engineering


     
    Dr.Wang Peng
    Vice President of Yabao Pharmaceutical Group
    President of Beijing Institute of Drug Research of Yabao
    President of Suzhou Yabao Pharmaceutical R & D Co., Ltd
     

     
    Embracing open innovation
     
    Recently,the American Institute for Medical and Biological Engineering informed that Dr. Wang Peng was elected as a fellow of the American Institute for Medical and Biological Engineering for his Outstanding contribution in this field. And he was also invited to attend the inauguration ceremony in Washington, DC, USA, on March 19-20th, 2017.
     
    About American Institute for Medical and Biological Engineering
     

     
    AIMBE is a prestigious, nonprofit organization in the field of international medical and biological engineering in Washington, DC, and it belongs to the American Academy of Sciences. The AIMBE Fellow is made up of the top 2% of the world's medical and bioengineering professionals. It must be recommended by the current members, then screened in two rounds and finally voted by the whole body to constitute.
     
    AIMBE College of Fellows brings together 1,500 leaders form academia, industry and government, and the most innovative and distinctive fields of medicine and bioengineering. They all work for a common goal that is to improve the health care and safety in society! There are seven people won the President's Science and Technology Innovation Award; 132 of them were members of United States National Academy of Engineering; 41 were members of American Academy of Medical Sciences and 94 were fellows of United States National Academy of Sciences.

     


     
    About Dr. Wang Peng
     
    Dr. Wang Peng, a distinguished experton the list of our country's "The Recruitment Program of Global Experts". He is now the Vice President of YabaoPharmaceutical Group, the President of Beijing Drug ResearchInstitute of Yabao and the President of Suzhou Yabao Pharmaceutical R & D Co., Ltd. .
     
    He has been engaged in the research and development of innovative drugs for 18 years in the Schering-Plough Institute of the United States. He has made significant contributions to the discovery and early development of nine candidate drugs. In 2008, he was hired by Shanghai Look Chem as its vice president and the head of the R &D of biology. In 2009,Wang Peng was invited to join Simcere Pharmaceutical Group as vice president and chief scientific officer; in 2013, he formally joined YaBao medicine, and served as president of Beijing Institute of drug research. And  in 2014, he set up a biological drugs company - Suzhou Yabao drug R & D Co.,Ltd.that commit to develop some revolutionary innovation drugs with international prospects through international cooperation.



友情连接:上海网站制作 上海网页制作 礼仪模特 上海活动策划公司 上海保安公司 上海保镖公司

×
×